Banerjee, Geetanjoli
Perera, Sue
Mu, Fan
Cook, Erin
Cheng, Mu
Zhang, Adina
Lan, Jessie Jie
Zou, Lin
Sikirica, Vanja https://orcid.org/0000-0003-1934-2222
Funding for this research was provided by:
Moderna, Inc. (NA)
Article History
Received: 5 February 2025
Accepted: 1 July 2025
First Online: 15 July 2025
Declarations
:
: Institutional Review Board review was not required for this study as it used retrospective deidentified claims data that comply with Health Insurance Portability and Accountability Act regulations. Specifically, studies using retrospective deidentified claims data do not meet the definition of research in human subjects per Title 45 of CFR, Part 46.102(e)(1) and thus, the policy for protection of human research subjects as outlined in Title 45 of CFR, Part 46, including approval or exemption of research from IRB review, does not apply to this study.
: Not applicable.
: GB, SP, and VS are employees of Moderna Therapeutics, Inc. FM, EC, MC, AZ, JL, and LZ are employees of Analysis Group, Inc, a consulting firm that received fees from Moderna Therapeutics, Inc. to conduct this study.